Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,265 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,265 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,265 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,265 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,265 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,265 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,265 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
13 Mar 2026
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 8×
$5.11M 9,500 at 538.00
98.7%
Sold half or more
13 Mar 2026
Kumar Neil Chief Executive Officer · indirect
Sold on a plan 4×
$2.75M 40,000 at 68.80
5.9%
Planned (10b5-1)
13 Mar 2026
Huffman Steve Ladd CEO & President · indirect
Sold on a plan 5×
$2.39M 18,000 at 132.86
4.2%
Planned (10b5-1)
13 Mar 2026
Mat Ishbia President and CEO · indirect
Sold on a plan
$2.34M 632,874 at 3.69
21.3%
Planned (10b5-1)
13 Mar 2026
Sold on a plan 4×
$2.08M 8,000 at 259.95
0.8%
Planned (10b5-1)
13 Mar 2026
Japan Post Holdings Co., Ltd. 10% owner · indirect
Sold on a plan 2×
$1.90M 17,400 at 109.14
0.0%
Planned (10b5-1)
13 Mar 2026
Khattar Jack A. President, CEO · indirect
Sold on a plan 3×
$1.76M 35,000 at 50.37
3.5%
Planned (10b5-1)
13 Mar 2026
Tarbert Heath President
Sold on a plan 6×
$1.74M 15,000 at 116.04
2.5%
Planned (10b5-1)
13 Mar 2026
Wu Lei Chief Executive Officer · indirect
Sold on a plan 2×
$1.24M 30,000 at 41.36
12.5%
Planned (10b5-1)
13 Mar 2026
Manthripragada Vijay President & CEO
Sold on a plan
$1.17M 46,121 at 25.41
16.3%
Planned (10b5-1)
13 Mar 2026
Bozic Carmen EVP and CMO
Sold on a plan
$1.12M 2,329 at 481.79
6.2%
Planned (10b5-1)
13 Mar 2026
Shah Shardul Director · indirect
Sold on a plan 2×
$1.01M 7,916 at 127.00
2.4%
Planned (10b5-1)
13 Mar 2026
Koning John Todd CHIEF FINANCIAL OFFICER
Sold on a plan
$986.19K 79,789 at 12.36
11.7%
Planned (10b5-1)
13 Mar 2026
HERRAIZ LIZETTE BENEDI GENERAL COUNSEL
Sold on a plan 2×
$607.59K 7,598 at 79.97
11.5%
Planned (10b5-1)
13 Mar 2026
Dabiri John Director
Sold on a plan
$555.44K 3,004 at 184.90
16.9%
Planned (10b5-1)
13 Mar 2026
Daggs Nicole J EVP, Human Res & Corp Svcs
Sold on a plan 2×
$458.86K 4,934 at 93.00
22.6%
Planned (10b5-1)
13 Mar 2026
LINK RAYMOND A Director
Sold on a plan
$420.43K 6,644 at 63.28
7.9%
Planned (10b5-1)
13 Mar 2026
MORTIMER IAN PRESIDENT & CEO
Sold on a plan
$403.58K 7,308 at 55.23
26.8%
Planned (10b5-1)
13 Mar 2026
Shirley Brian Director · indirect
Sold on a plan
$382.77K 1,234 at 310.19
18.1%
Planned (10b5-1)
13 Mar 2026
Rodman David Malcom Chief Medical Officer
Sold on a plan 3×
$369.23K 14,058 at 26.26
15.6%
Planned (10b5-1)
13 Mar 2026
MAETZOLD DEREK J Pres. & Chief Exec. Officer
Sold on a plan
$336.00K 13,204 at 25.45
18.5%
Planned (10b5-1)
13 Mar 2026
Sold on a plan
$328.30K 7,930 at 41.40
7.0%
Planned (10b5-1)
13 Mar 2026
Zedelmayer Christine Sr. Vice President and COO
Sold on a plan
$300.82K 120,312 at 2.50
65.8%
Sold half or more
13 Mar 2026
HEADEN CYNTHIA A EVP, Chief Supply Chain Offr
Sold on a plan
$292.62K 738 at 396.50
10.6%
Planned (10b5-1)
13 Mar 2026
BENDHEIM JACK President and CEO · indirect
Sold on a plan
$258.24K 5,280 at 48.91
5.2%
Planned (10b5-1)
13 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$247.02K 19,060 at 12.96
3.6%
Planned (10b5-1)
13 Mar 2026
Harmer Derek Chief Compliance Officer
Sold on a plan
$227.80K 20,000 at 11.39
10.0%
Planned (10b5-1)
13 Mar 2026
Mutz Christopher HEAD OF RARE DISEASE
Sold on a plan
$226.53K 3,162 at 71.64
3.3%
Planned (10b5-1)
13 Mar 2026
Cobb Stuart Chief Scientific Officer
Sold on a plan 3×
$141.45K 6,797 at 20.81
18.2%
Planned (10b5-1)
13 Mar 2026
Sandeep Reddy EVP, Chief Financial Officer
Sold on a plan
$121.73K 307 at 396.50
3.3%
Planned (10b5-1)
13 Mar 2026
BAKER COREY Chief Financial Officer
Sold on a plan
$117.72K 2,000 at 58.86
5.6%
Planned (10b5-1)
13 Mar 2026
Sold on a plan
$106.54K 1,000 at 106.54
5.7%
Planned (10b5-1)
13 Mar 2026
Cvijic Christine Mikail President and CFO
Sold on a plan 3×
$84.18K 4,045 at 20.81
3.7%
Planned (10b5-1)
13 Mar 2026
Kirchhoff Benjamin Louis CHIEF ACCOUNTING OFFICER
Sold on a plan
$79.11K 2,480 at 31.90
2.1%
Planned (10b5-1)
13 Mar 2026
KENNEY CHRISTOPHER JOHN Chief Medical Officer
Sold on a plan
$77.87K 1,410 at 55.23
16.6%
Planned (10b5-1)
13 Mar 2026
DiFabio Andrea Chief Legal Officer
Sold on a plan
$74.11K 1,342 at 55.23
15.5%
Planned (10b5-1)
13 Mar 2026
EGLINTON MANNER CARRIE President & CEO
Bought on a plan
$66.03K 22,022 at 3.00
1.0%
Bought on a plan
13 Mar 2026
McGrath Kenneth J Chief Financial Officer
Bought on a plan
$66.03K 22,021 at 3.00
4.1%
Bought on a plan
13 Mar 2026
Moore Jocelyn Director
Sold on a plan
$55.04K 2,150 at 25.60
60.5%
Sold half or more
13 Mar 2026
Sold on a plan
$42.27K 112 at 377.44
0.6%
Planned (10b5-1)
13 Mar 2026
ROTHBLATT MARTINE A Chairperson & CEO · indirect
Sold on a plan
$40.27K 75 at 536.95
0.0%
Planned (10b5-1)
13 Mar 2026
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$36.31K 500 at 72.62
0.6%
Planned (10b5-1)
13 Mar 2026
Cook Steven L. Chief Financial Officer
Sold on a plan
$26.26K 1,884 at 13.94
0.9%
Planned (10b5-1)
13 Mar 2026
Chapman Rowan E Director
Sold on a plan
$23.35K 122 at 191.38
2.1%
Planned (10b5-1)
13 Mar 2026
LEVIN ARTHUR A Director
Sold on a plan
$22.26K 605 at 36.80
12.5%
Planned (10b5-1)
13 Mar 2026
MADDEN LARRY Chief Financial Officer
Sold on a plan
$21.61K 1,658 at 13.03
0.4%
Planned (10b5-1)
13 Mar 2026
PARRISH JESSICA L VP, Chief Accounting Officer
Sold on a plan
$18.64K 47 at 396.50
1.4%
Planned (10b5-1)
13 Mar 2026
Wu Naixi Chief Financial Officer
Sold on a plan
$15.08K 6,000 at 2.51
7.8%
Planned (10b5-1)
13 Mar 2026
McGrane Ashley General Counsel and Corp Sec
Sold on a plan
$12.29K 2,045 at 6.01
3.5%
Planned (10b5-1)
13 Mar 2026
POSEY BRUCE K CHIEF LEGAL OFFICER
Sold on a plan
$6.51K 65 at 100.09
0.1%
Planned (10b5-1)
Showing 14,651–14,700 of 23,265. ← Newer Page 294 of 466 Older →